Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of Chi...
Fuan Pharmaceutical released its performance for the first three quarters, with a net profit attributable to the parent company of 166 million yuan, a decrease of 44.87%
Fuan Pharmaceutical Announcement on the Implementation of the 2025 Half-Year Equity Distribution Plan
Fuan Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 113 million yuan, a decrease of 47.74%
Asian Market Highlights: Penny Stocks To Watch In August 2025
The chemical pharmaceutical sector sees a short-term surge, with Fuan Pharmaceutical rising over 10%
Industrial hemp concept stocks opened strong, with Rhine Biotech hitting the daily limit